Cargando…

Technical developments in transurethral resection of bladder tumours

Bladder cancer is one of the most common malignancies worldwide. The transurethral resection of bladder tumour (TURB) remains the gold standard in both diagnostics and treatment. Because of the importance of TURB in bladder cancer management and the fact that TURB is one of the most commonly perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastuszak, Agata, Zdrojowy, Romuald, Poletajew, Sławomir, Adamowicz, Jan, Krajewski, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978765/ https://www.ncbi.nlm.nih.gov/pubmed/31992950 http://dx.doi.org/10.5114/wo.2019.91530

Ejemplares similares

En-bloc resection of urinary bladder tumour – a prospective controlled multicentre observational study
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors
por: Krajewski, Wojciech, et al.
Publicado: (2021)

Bladder perforation during transurethral resection of bladder tumour is not a result of a deficient structure of the bladder wall
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
por: Krajewski, Wojciech, et al.
Publicado: (2018)

Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour – a prospective multicentre observational study
por: Poletajew, Sławomir, et al.
Publicado: (2019)

Pain reduction methods during transurethral cystoscopy
por: Łaszkiewicz, Jan, et al.
Publicado: (2021)

Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
por: KRAJEWSKI, WOJCIECH, et al.
Publicado: (2020)

Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer
por: Krajewski, Wojciech, et al.
Publicado: (2018)

Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study
por: Mielczarek, Łukasz, et al.
Publicado: (2020)

Transurethral resection of bladder tumour (TURBT)
por: Kim, Lawrence H. C., et al.
Publicado: (2020)

Oncological outcomes of laparoscopic versus open nephroureterectomy for the treatment of upper tract urothelial carcinoma: an updated meta-analysis
por: Piszczek, Radosław, et al.
Publicado: (2021)

The TaHG bladder cancer – the devil is as black as he is painted
por: Krajewski, Wojciech, et al.
Publicado: (2019)

Contemporary surgical and technical aspects of transurethral resection of bladder tumor
por: Ouzaid, Idir, et al.
Publicado: (2019)

Lack of evidence for increased level of circulating urothelial cells in the peripheral blood after transurethral resection of bladder tumors
por: Antoniewicz, Artur A., et al.
Publicado: (2011)

Transurethral resection of bladder tumours: established and new methods of tumour visualisation
por: Tully, Karl, et al.
Publicado: (2019)

Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
por: Roumiguié, Mathieu, et al.
Publicado: (2020)

Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer
por: Zapała, Piotr, et al.
Publicado: (2018)

Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
por: Poletajew, Sławomir, et al.
Publicado: (2020)

The role of lasers in modern urology
por: Dołowy, Łukasz, et al.
Publicado: (2015)

Vitamin D and urological cancers
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Salvage local therapy for radiation-recurrent prostate cancer – where are we?
por: Zdrojowy, Romuald, et al.
Publicado: (2016)

How to lower postoperative complications after radical cystectomy – a review
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Evaluation and physiopathology of minor transient shock wave lithotripsy – induced renal injury based on urinary biomarkers levels
por: Dzięgała, Mateusz, et al.
Publicado: (2018)

Urological complications after radiation therapy—nothing ventured, nothing gained: a Narrative Review
por: Chorbińska, Joanna, et al.
Publicado: (2021)

Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer
por: Ozer, Kutan, et al.
Publicado: (2015)

Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer—narrative review
por: Piszczek, Radosław, et al.
Publicado: (2020)

Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy
por: Piszczek, Radosław, et al.
Publicado: (2020)

The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status
por: Nowak, Łukasz, et al.
Publicado: (2020)

Obturator Nerve Block for Transurethral Resection of Bladder Tumors
por: Gavrilovska-Brzanov, Aleksandra, et al.
Publicado: (2023)

Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer
por: Zhou, Yu, et al.
Publicado: (2020)

Is ‘second-look’ (re-staging) transurethral resection of bladder tumours a new standard of care?
por: Herr, Harry, et al.
Publicado: (2011)

National Implementation of Simulator Training Improves Transurethral Resection of Bladder Tumours in Patients
por: Bube, Sarah H., et al.
Publicado: (2022)

Management of bladder pheochromocytoma by transurethral resection
por: Sharma, Aditya P., et al.
Publicado: (2019)

Pathogenicity of BK virus on the urinary system
por: Krajewski, Wojciech, et al.
Publicado: (2020)

Transurethral resection syndrome: A rare complication of intraperitoneal bladder perforation during transurethral resection of bladder tumor
por: Ibrahimi, Ahmed, et al.
Publicado: (2020)

The value of extended good quality transurethral resection of bladder tumour in the treatment of the newly diagnosed bladder cancer
por: Atta, Mohamed Adel, et al.
Publicado: (2016)

Preoperative pyuria predicts the presence of high-grade bladder carcinoma in patients with bladder tumors
por: Poletajew, Sławomir, et al.
Publicado: (2020)

Value of separate tumor base biopsy in transurethral resection of bladder tumors
por: Sionov, Ben Valery, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ddl7b5afmrin012hfkd0u3pu8j